A hallmark of neoplastic transformation by DNA tumor viruses is the deregulation of cell cycle genes. At least in some genes, this deregulation appears to be due to the oncoprotein-mediated disruption of complexes between E2F and pocket proteins and the ensuing generation of transcriptionally active free E2F. In the present study, we have analysed the eect of the SV40 large T oncoprotein (SV-LT) on the function of a dierent cell cycle-regulated transcriptional repressor, CDF, which is the principal regulator of the cdc25C, cyclin A and cdc2 genes. As shown by genomic footprinting of sorted G 1 and G 2 cell populations, transformation by SV-LT completely abrogated protection of the CDF binding site (CDE-CHR) in the cdc25C promoter. In agreement with this observation, expression of the SV-LT in ®broblasts led to a dramatic up-regulation of the cdc25C promoter in cells synchronized in G 0 . These ®ndings indicate that the oncoprotein-mediated dissociation of the CDF repressor protein from its cognate DNA-binding site is a major mechanism in virus-induced transcriptional deregulation.
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The transcriptional deregulation of cell cycle genes appears to be a major strategy employed by the oncoproteins of DNA tumor viruses to override growth control mechanisms in mammalian cells (Buchou et al., 1993; Oshima et al., 1993; Spitkovsky et al., 1994; Cheng et al., 1995; Schulze et al., 1995; Chang et al., 1997) . Oncoproteins, including the adenovirus E1a gene product, the SV40 large T antigen (SV-LT), and the human papilloma virus E7 protein, bind pocket proteins through regions which are necessary for transformation (DeCaprio et al., 1989; Dyson et al., 1989) . These interactions with pocket proteins lead to the disruption of the complex between the transcription factor E2F and pocket proteins (Chellappan et al., 1992; Dyson et al., 1993) releasing transcriptionally active free E2F, which in turn leads to an inappropriate transcriptional up-regulation of E2F target genes (Nevins, 1992) . Another class of cell cycle genes is regulated by a mechanism of transcriptional repression that does not involve the transcription factor E2F. The proto-type of this group of genes is cdc25C (Lucibello et al., 1995) , which is controlled by a novel repressor, termed CDF-1 (Liu et al., 1997) . CDF-1 binds cooperatively to two contiguous elements, the CDE and CHR (Zwicker et al., 1995b) and seems to be unrelated to all known E2F and DP family members (Liu et al., 1997) . CDF-1 is also the major regulator of the cyclin A gene (Zwicker et al., 1995b) . As shown by in vivo footprinting, occupation of the CDE and CHR elements is inversely correlated with promoter activity during the cell cycle, and mutations in either element lead to constitutive transcription (Lucibello et al., 1995; Zwicker et al., 1995b) . It is however unclear what the eect of viral oncoproteins on CDF-1 mediated repression is. The goal of the present study was therefore to address this issue by analysing the eect of the SV-LT on the cdc25C repressor.
To this end we ®rst performed genomic footprinting of the cdc25C promoter. Normally growing WI38 cells and WI38 cells expressing the SV-LT (WI38VA13 cells) were sorted by¯uorescence-activated cell sorting (FACS) after dimethyl sulfate (DMS) treatment and ®xation. This procedure yielded almost pure fractions of G 1 and G 2 cells (Figure 1 ). As previously reported (Lucibello et al., 1995) , the CDE in cdc25C promoter was protected in WI38 cells in the G 1 phase, and this occupation is lost in G 2 (see insert in Figure 2 ). By contrast, in WI38VA13 cells the cdc25C CDE was unprotected in both G 1 and G 2 , although the interactions with constitutively bound NF-Y in the upstream region were unaected by expression of SV40 large T (Figure 2 ). These data clearly indicate that the SV-LT disrupts protein interactions at the CDE-CHR elements in the cdc25C promoter.
A prediction from the loss of CDE-CHR occupation in G 0 cells would be a deregulation of transcription during cell cycle progression. We therefore analysed the eect of SV-LT expression on the cdc25C promoter in transient luciferase assays. NIH3T3 cells were cotransfected with a cdc25C promoter construct and an SV-LT expression plasmid (or the empty vector as the control) and the luciferase activities were determined 60 h later in both normally cycling cells and in cells synchronized by G 0 by serum deprivation. As can be seen in Figure 3 , the SV-LT expression vector led to an approximately 2.5-fold increase in luciferase activity in the normally cycling cells, and a *ninefold increase in G 0 cells. The increase in the normally cycling cells is presumably due to an eect on the G 1 fraction (*60% of the cell population) where CDF-1 is active. Only a marginal eect of SV-LT was seen with a reporter plasmid containing a mutated CDE (Lucibello et al., 1995; Zwicker et al., 1995b ) (data not shown), indicating that CDF-1 is an essential target in the deregulation of the cdc25C promoter by the viral oncoprotein.
In order to verify that the increased luciferase activity of SV-LT was due to a direct action of SV-LT on the cdc25C promoter rather than due to the oncoprotein-induced cell cycle progression of G 0 /G 1 cells, we cotransfected NIH3T3 cells with the same SV40 expression plasmid and an expression vector (pEGFP; Clontech) for an FACS-optimized form of green¯uorescent protein (GFP) (Cormack et al., 1996) . Cells were synchronized in G 0 as above. Sixty hours post-transfection the cells were stained with Hoechst 33258 and FACS analyses were performed to measure the DNA content of GFP-positive (i.e., successfully transfected) and GFP-negative (i.e., untransfected) cells. This analysis showed only marginal dierences in the cells transfected with the SV-LT expression vector and the empty vector, respectively. The cell cycle distributions were 79.6+2.7% G 0 /G 1 and 20.4+2.6% S/G 2 for cell transfected with the SV-LT expression vector, and 79.5+2.9% G 0 /G 1 and 20.5+2.9% S/G 2 Figure 1 FACS analysis of WI38 and WI38VA13 cells and sorted G 1 and G 2 fractions after staining with Hoechst 33258. The trypsinized cells were stained with Hoechst 33258 and sorted according to DNA content using a Becton-Dickinson FACStar Plus (Lucibello et al., 1995) Figure 2 Genomic DMS footprinting of the cdc25C promoter in sorted G 1 and G 2 fractions of WI38VA13 cells. The positions of the CDE and the NF-Y binding sites (Lucibello et al., 1995; Zwicker et al., 1995a) are indicated. In vivo footprinting was performed exactly as described (Lucibello et al., 1995; Zwicker et al., 1995b) . Preparative cell sorting was carried out as in Figure 1 at a rate of 1000 cells/sec. WI38 and WI38VA13 (ATCC CCL 75.1) were cultured in DMEM/MCDB105 (ratio 1 : 1) supplemented with 10% fetal calf serum for cell transfected with the empty expression vector. These ®ndings suggest that SV-LT has no signi®cant eect on NIH3T3 cells in G 0 . Taken together, our observations therefore demonstrate that SV-LT abrogates repression of the cdc25C promoter which is fully consistent with the genomic footprinting data showing a loss of CDF-DNA interaction. Our observations are also in agreement with published data showing that SV-LT expressing cells contain elevated levels of Cdc25C (Chang et al., 1997) .
The results presented in this study clearly suggest that the inactivation of CDF-1 by viral oncoproteins is crucial for the virus-induced deregulation of cell cycle genes. If one considers the fact that a number of important cell cycle genes including cyclin A and cdc2 are under the negative control of CDF-1, it is likely that CDF-1 inactivation is a critical step in virusinduced transformation. It is also clear that the inactivation of CDF-1 is due to the SV-LT mediated inhibition of DNA-binding. In this respect, the action of SV-LT on CDF and E2F is fundamentally dierent, since viral oncoproteins are generally believed to convert DNA-binding inactive or repressing E2F complexes (E2F-pocket protein complexes) into DNA-binding activating E2F (`free E2F'). It has been shown that E7, apart from releasing E2F from hypophosphorylated pocket proteins, also targets pRb and p107 for degradation through the ubiquitinproteasome pathway (Boyer et al., 1996; Jones and Munger, 1997) . At present we cannot clarify whether a similar molecular mechanism underlies the inactivation of CDF-1 by SV-LT. However, the cloning of CDF-1 cDNA is under way so that the anticipated availability of recombinant protein and antibodies should enable us to address this intriguing question in future investigations. Figure 3 Deregulation of cdc25C transcription in NIH3T3 cells in a normally cycling state and synchronized in G 0 . NIH3T3 cells cultured in DMEM containing 10% fetal calf serum were cotransfected with an SV40 promoter/enhancer-driven SV-LT expression plasmid (SV-LT) or the empty vector (Con) plus the cdc25C promoter luciferase construct C290 (Lucibello et al., 1995; Zwicker et al., 1995b) . pMSPE was used as the expression vector (Schuermann, 1990) . For synchronization in G 0 the cells were serum-deprived for 48 h 12 h post-transfection. Luciferase activities were measured 60 h post-transfection as described (Lucibello et al., 1995) 
